
- Oncology NEWS International Vol 18 No 9
- Volume 18
- Issue 9
Green tea may slow prostate ca progression
Men with prostate cancer who consumed the active compounds in green tea demonstrated a significant reduction in serum markers predictive of prostate cancer progression, according to a study in Cancer Prevention Research (online June 19, 2009).
Men with prostate cancer who consumed the active compounds in green tea demonstrated a significant reduction in serum markers predictive of prostate cancer progression, according to a study in Cancer Prevention Research (online June 19, 2009). In their open-label, single-arm, phase II clinical trial, James A. Cardelli, PhD, and colleagues determined the effects of green tea’s active compounds on serum biomarkers, including hepatocyte growth factor (HGF), VEGF, and PSA.
After consuming what amounts to 12 cups of green tea daily for anywhere from 12 to 73 days, HGF, VEGF, and PSA serum levels fell by more than 30% in some patients, according to the authors who are based at Feist-Weiller Cancer Center at Louisiana State University Health Sciences Center in Shreveport.
Articles in this issue
about 16 years ago
Industry Watchabout 16 years ago
Letter to the Editorabout 16 years ago
Novel chemoRT regimen ups survival in pancreatic caabout 16 years ago
Low expression of MSH2 protein predicts survival in NSCLCabout 16 years ago
Prostate cancer pilot program stresses patient-oriented careabout 16 years ago
CT distinguishes liver cancer mets from lung primaryabout 16 years ago
Prostate cancer patients seek out mind-body careabout 16 years ago
Who's Newsabout 16 years ago
Panitumumab plus FOLFIRI bests FOLFIRI alone as second-line colon ca RxNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.